Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of whey protein as broad-spectrum inhibitor of coronaviruses

A whey protein, coronavirus technology, applied in disease applications, whey protein field

Pending Publication Date: 2021-12-31
PEKING UNIV +2
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Although recent research reports have shown that a variety of candidate vaccines have shown good safety and efficacy in animal experiments and phase I clinical trials, and a series of drug molecule candidates have a certain ability to inhibit viruses, but there is still a long way to go. It is necessary to increase the screening and research of drugs to find drugs with better curative effect and better safety

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of whey protein as broad-spectrum inhibitor of coronaviruses
  • Application of whey protein as broad-spectrum inhibitor of coronaviruses
  • Application of whey protein as broad-spectrum inhibitor of coronaviruses

Examples

Experimental program
Comparison scheme
Effect test

experiment example

[0027] Experimental Example: Effect of Whey Protein on Inhibiting Coronavirus Infection

[0028] Detection principle: xCoV is highly homologous to SARS-CoV-2. Through the comparison and analysis of the whole genome and each viral coding gene (nucleotide level and amino acid level), it is found that: xCoV is highly homologous to SARS-CoV-2, and is highly homologous to SARS-CoV The homology of the S protein of -2 reaches 92.5%, which is the virus with the highest homology to the S protein of SARS-CoV-2 that has been successfully isolated and cultured so far, whether it is the whole genome level or the key gene S gene for virus adsorption into cells , the homology of xCoV and SARS-CoV-2 is much higher than that of SARS virus, such as figure 1 shown.

[0029] The inventors used an alternative model of SARS-CoV-2, the xCoV virus model, to avoid the risk and cumbersomeness of P3 laboratory experiments. The xCoV virus can be cultivated in ordinary P2 laboratories, and can be used a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides novel application of whey protein and degraded products thereof. The whey protein and the degraded products thereof can be used for preventing and / or treating diseases caused by coronaviruses such as serious acute respiratory syndrome coronavirus (SARS-CoV), novel coronavirus (SARS-CoV-2) and similar novel coronaviruses such as pangolin coronavirus (xCoV) as broad-spectrum inhibitors of the coronaviruses. The whey protein can be used for inhibiting adhesion, entry and replication of viruses, is an effective multi-target inhibitor and is high in safety, so that the whey protein can be applied to prevention and / or treatment of the diseases caused by the coronaviruses.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to the application of whey protein for preventing and / or treating diseases caused by coronaviruses. Background technique [0002] The 2019 novel coronavirus (2019-nCoV or SARS-CoV-2, which causes novel coronavirus pneumonia COVID-19) is currently the seventh known coronavirus that can infect humans, and the remaining six are HCoV-229E, HCoV- OC43, HCoV-NL63, HCoV-HKU1, SARS-CoV and MERS-CoV. Among them, HCoV-229E, HCoV-OC43, HCoV-NL63 and HCoV-HKU1 are less pathogenic and generally cause respiratory symptoms, similar to the common cold or pneumonia. The other three are highly pathogenic and infectious, and the diseases they cause include severe acute respiratory syndrome (SARS, 2002-2004), Middle East respiratory syndrome (MERS, 2012-present) and new coronavirus disease (COVID-19). Therefore, how to block the spread of coronavirus, prevent infection and develop new effective d...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/38A61K38/17A61P31/14
CPCA61K38/38A61K38/1709A61P31/14
Inventor 向宽辉范华昊周乙华庄辉童贻刚李彤骆予倩宋立华安小平王立钦胡运甲金香淑洪碧霞
Owner PEKING UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com